2020 policy changes in Canada will create additional scrutiny on pharmaceutical pricing
Read our interview with Olaf Koester on significant changes to the Patented Medicines Regulations set to go into effect July 1, 2020.
Read our interview with Olaf Koester on significant changes to the Patented Medicines Regulations set to go into effect July 1, 2020.
In this on-demand webinar, a panel of Precision's top gene and cell therapy leaders tackles the challenge of how to demonstrate the short and long-term value of a therapy when clinical data is lacking.
Adapted from recent presentations at the AMCP and ISPOR conferences, this webinar will provide an overview of value-based contracting and some of the key challenges to successful implementation.
This expert panel tackle head-on some of the hottest topics and trends in health economics and outcomes research today, and what you need to know to be successful in 2020.
Hosted by the AMCP in collaboration with Precision Xtract, this unique half-day interactive training program will be led by Precision’s Stephen Carter.
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ